🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè

Etid klinik pou Kansè Vezik ki pa envazif miskilè ap rekrite nan Etazini

33 etid pou Kansè Vezik ki pa envazif miskilè ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06833073

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07206225

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05796375

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06503614

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07144319

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT06637423

Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Ap rekriteEtid obsèvasyon
Laj 18 a 99 · Tout sèks · Mizajou Aug 24, 2026 · NCT05825950

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Ap rekriteFaz 3
Laj 21 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06929286

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

A Phase I Intravesical PPM Therapy for NMIBC

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05519241

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05126472

Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT07763197

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07225127

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07673016

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT05710848

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Ap rekriteFaz 2
Laj 18 a 99 · Tout sèks · Mizajou Apr 17, 2026 · NCT07322263

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT06704191

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.